![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 20, 2023 10:25:16 PM
You will see billions in revenue if we get a covid EUA. I think Paxlovid, which was generating about $13B for Pfizer, could lose a substantial part of the therapeutic market to lenz, especially now that studies are showing rebound cases of covid are 10X higher than Pfizer claimed. Their vaccine could also lose market share to Novavax, if their protytype vaccine incorporates a lenz adjuvant.
I think you're smarter than what is reflected in your posts. I hope you will reassess your statements.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM